103 related articles for article (PubMed ID: 38767546)
1. Clinical characteristics and treatment outcomes of patients with IgG4-positive ocular adnexal marginal zone B-cell lymphoma.
Yang Y; Jin X; Xu M; He W
Indian J Ophthalmol; 2024 May; ():. PubMed ID: 38767546
[TBL] [Abstract][Full Text] [Related]
2. Clinical analysis of ocular adnexal mucosa-associated lymphoid tissue lymphoma with IgG4-related ophthalmic disease.
Yoon J; Kim KJ; Sa HS
Orbit; 2022 Oct; 41(5):551-557. PubMed ID: 34369286
[TBL] [Abstract][Full Text] [Related]
3. Change of Serum IgG4 in Patients with Ocular Adnexal Marginal Zone B Cell Lymphoma Associated with IgG4-Related Ophthalmic Disease After Treatment.
Wu YH; Wang LC; Yen SH; Yu WK; Kao SC; Kau HC; Tsai CC; Liu CJ
J Ocul Pharmacol Ther; 2017 Sep; 33(7):543-548. PubMed ID: 28514197
[TBL] [Abstract][Full Text] [Related]
4. Treating synchronous bilateral ocular adnexal marginal zone lymphoma: the consortium for improving survival of lymphoma study.
Oh SY; Kim WS; Kang HJ; Lee JH; Huh SJ; Kim SJ; Yoon DH; Hong JY; Lee WS; Kim HJ; Won JH; Park BB; Lee SI; Suh C
Ann Hematol; 2018 Oct; 97(10):1851-1857. PubMed ID: 29947974
[TBL] [Abstract][Full Text] [Related]
5. Ocular adnexal marginal zone lymphoma arising in a patient with immunoglobulin-G4-related ophthalmic disease: A 4-year delay in diagnosis.
Sabt BI; Al Yahyai M; Al-Mujaini AA; Al-Mujaini AS
Saudi J Ophthalmol; 2021; 35(2):164-166. PubMed ID: 35391806
[TBL] [Abstract][Full Text] [Related]
6. Immunoglobulin G4 (IgG4)-Positive Ocular Adnexal Mucosa-Associated Lymphoid Tissue Lymphoma and Idiopathic Orbital Inflammation.
Sohn EJ; Ahn HB; Roh MS; Jung WJ; Ryu WY; Kwon YH
Ophthalmic Plast Reconstr Surg; 2018; 34(4):313-319. PubMed ID: 28749851
[TBL] [Abstract][Full Text] [Related]
7. Role of F-18 FDG PET/CT in non-conjunctival origin ocular adnexal mucosa-associated lymphoid tissue (MALT) lymphomas.
Park HL; O JH; Park SY; Jung SE; Park G; Choi BO; Kim SH; Jeon YW; Cho SG; Yang SW;
EJNMMI Res; 2019 Nov; 9(1):99. PubMed ID: 31754896
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological Analysis of Ocular Adnexal Extranodal Marginal Zone B-Cell Lymphoma with IgG4-Positive Cells.
Lee MJ; Kim N; Choe JY; Khwarg SI; Jeon YK; Choung HK; Kim JE
PLoS One; 2015; 10(6):e0131458. PubMed ID: 26111022
[TBL] [Abstract][Full Text] [Related]
9. [Clinical and pathological study on IgG4-related ophthalmic disease involving the lacrimal gland].
Li HQ; Lin JY; Zhao H
Zhonghua Yan Ke Za Zhi; 2019 Nov; 55(11):834-841. PubMed ID: 31715680
[No Abstract] [Full Text] [Related]
10. Follow-up with serum IgG4-monitoring in 8 patients with IgG4-related disease diagnosed by a lacrimal gland mass.
Matsuo T; Tanaka T; Sato Y; Kataoka H; Uka M; Ennishi D; Yano T
J Clin Exp Hematop; 2021; 61(1):10-21. PubMed ID: 33731547
[TBL] [Abstract][Full Text] [Related]
11. Local recurrence as immunoglobulin G4 (IgG4)-related disease 10 years after radiotherapy to ocular adnexal extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue.
Matsuo T; Ichimura K; Yoshino T
J Clin Exp Hematop; 2011; 51(2):125-33. PubMed ID: 22104312
[TBL] [Abstract][Full Text] [Related]
12. Long-term survival outcomes of patients with primary ocular adnexal MALT lymphoma: A large single-center cohort study.
Liang Y; Fu RY; Liu XL; Liu XD; Piao YS; Ma JM; Wang L
Cancer Med; 2023 Feb; 12(3):2514-2523. PubMed ID: 35906828
[TBL] [Abstract][Full Text] [Related]
13. Ocular adnexal IgG4-related disease: clinical features, outcome, and factors associated with response to systemic steroids.
Yu WK; Kao SC; Yang CF; Lee FL; Tsai CC
Jpn J Ophthalmol; 2015 Jan; 59(1):8-13. PubMed ID: 25373451
[TBL] [Abstract][Full Text] [Related]
14. [Treatment and prognosis of primary ocular adnexal extranodal marginal zone mucosa-associated lymphoid tissue lymphoma: a report from a single center].
Li X; Ye J; Yang L; Wei LQ; Cong J; Yao N; Yang J; Wang JW
Zhonghua Xue Ye Xue Za Zhi; 2022 Mar; 43(3):209-214. PubMed ID: 35405778
[No Abstract] [Full Text] [Related]
15. Ocular adnexal marginal zone lymphoma arising in a patient with IgG4-related ophthalmic disease.
Nishida K; Sogabe Y; Makihara A; Senoo A; Morimoto H; Takeuchi M; Gion Y; Yoshino T; Sato Y
Mod Rheumatol; 2019 Mar; 29(2):383-387. PubMed ID: 27686866
[TBL] [Abstract][Full Text] [Related]
16. Ocular adnexal marginal zone B cell lymphoma infiltrated by IgG4-positive plasma cells.
Kubota T; Moritani S; Yoshino T; Nagai H; Terasaki H
J Clin Pathol; 2010 Dec; 63(12):1059-65. PubMed ID: 20980530
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Selection and Long-term Clinical Outcomes Between Chemotherapy and Radiotherapy as Primary Therapeutic Modality for Ocular Adnexal MALT Lymphoma.
Jeon YW; Yang HJ; Choi BO; Jung SE; Park KS; O JH; Yang SW; Cho SG
EClinicalMedicine; 2018; 4-5():32-42. PubMed ID: 31193655
[TBL] [Abstract][Full Text] [Related]
18. Malignancies in Immunoglobulin G4-related ophthalmic disease.
Lai KKH; Li EYM; Chan RYC; Wong KCW; Yu JKS; Cheuk W; Hui YH; Cheng ACO; Chin JKY; Ip SK; Chan WH; Kwok JSW; Lam WC; Io IYF; Mak TST; Li KKW; Lam NM; Yip WWK; Young AL; Chan E; Ko CKL; Ko STC; Yuen HKL; Tham CCY; Pang CP; Chong KKL
Eur J Ophthalmol; 2023 Jan; 33(1):171-181. PubMed ID: 35675196
[TBL] [Abstract][Full Text] [Related]
19. Diffuse large B-cell lymphoma and mantle cell lymphoma of the ocular adnexal region, and lymphoma of the lacrimal gland: an investigation of clinical and histopathological features.
Rasmussen PK
Acta Ophthalmol; 2013 Jul; 91 Thesis 5():1-27. PubMed ID: 24041159
[TBL] [Abstract][Full Text] [Related]
20. Low-dose 'boom-boom' radiotherapy for ocular lymphoma arising from IgG4-related ophthalmic disease: Case report and literature review.
Meng K; Lim MC; Poon MLM; Sundar G; Vellayappan B
Eur J Ophthalmol; 2022 Nov; 32(6):NP78-NP84. PubMed ID: 34030509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
